• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用残疾调整生命年(DALYs)评估西班牙十二种免疫预防传染病对人群健康的影响。

Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain.

机构信息

Medical Direction, Complejo Asistencial de Ávila, Ávila, Spain.

Carlos III University, Madrid, Spain.

出版信息

BMC Infect Dis. 2024 Aug 5;24(1):779. doi: 10.1186/s12879-024-09637-x.

DOI:10.1186/s12879-024-09637-x
PMID:39103777
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11299363/
Abstract

BACKGROUND

The objective of this study is to estimate the burden of selected immunization-preventable infectious diseases in Spain using the Burden of Communicable Diseases in Europe (BCoDE) methodology, as well as focusing on the national immunization programme and potential new inclusions.

METHODS

The BCoDE methodology relies on an incidence and pathogen-based approach to calculate disease burden via disability-adjusted life year (DALY) estimates. It considers short and long-term sequelae associated to an infection via outcome trees. The BCoDE toolkit was used to populate those trees with Spanish-specific incidence estimates, and de novo outcome trees were developed for four infections (herpes zoster, rotavirus, respiratory syncytial virus [RSV], and varicella) not covered by the toolkit. Age/sex specific incidences were estimated based on data from the Spanish Network of Epidemiological Surveillance; hospitalisation and mortality rates were collected from the Minimum Basic Data Set. A literature review was performed to design the de novo models and obtain the rest of the parameters. The methodology, assumptions, data inputs and results were validated by a group of experts in epidemiology and disease modelling, immunization and public health policy.

RESULTS

The total burden of disease amounted to 163.54 annual DALYs/100,000 population. Among the selected twelve diseases, respiratory infections represented around 90% of the total burden. Influenza exhibited the highest burden, with 110.00 DALYs/100,000 population, followed by invasive pneumococcal disease and RSV, with 25.20 and 10.57 DALYs/100,000 population, respectively. Herpes zoster, invasive meningococcal disease, invasive Haemophilus influenza infection and hepatitis B virus infection ranked lower with fewer than 10 DALYs/100,000 population each, while the rest of the infections had a limited burden (< 1 DALY/100,000 population). A higher burden of disease was observed in the elderly (≥ 60 years) and children < 5 years, with influenza being the main cause. In infants < 1 year, RSV represented the greatest burden.

CONCLUSIONS

Aligned with the BCoDE study, the results of this analysis show a persisting high burden of immunization-preventable respiratory infections in Spain and, for the first time, highlight a high number of DALYs due to RSV. These estimates provide a basis to guide prevention strategies and make public health decisions to prioritise interventions and allocate healthcare resources in Spain.

摘要

背景

本研究旨在使用欧洲传染病负担(BCoDE)方法学估算西班牙部分可通过免疫预防的传染病的负担,同时重点关注国家免疫规划和潜在的新增疫苗可预防疾病。

方法

BCoDE 方法学采用基于发病率和病原体的方法,通过残疾调整生命年(DALY)估算来计算疾病负担。它通过后果树考虑与感染相关的短期和长期后遗症。使用 BCoDE 工具包用西班牙特定的发病率估算值填充这些树,为工具包未涵盖的四种感染(带状疱疹、轮状病毒、呼吸道合胞病毒[RSV]和水痘)开发了新的后果树。基于西班牙流行病学监测网络的数据估计了年龄/性别特异性发病率;从最低基本数据集收集了住院和死亡率数据。对文献进行了回顾,以设计新模型并获得其余参数。流行病学和疾病建模、免疫和公共卫生政策方面的专家组对方法、假设、数据输入和结果进行了验证。

结果

疾病总负担为 163.54 个/10 万人年 DALY。在所选择的十二种疾病中,呼吸道感染约占总负担的 90%。流感的负担最高,为 110.00 个/10 万人年,其次是侵袭性肺炎球菌病和 RSV,分别为 25.20 和 10.57 个/10 万人年。带状疱疹、侵袭性脑膜炎球菌病、侵袭性流感嗜血杆菌感染和乙型肝炎病毒感染的排名较低,每人每年少于 10 个 DALY,而其余感染的负担有限(<1 个/10 万人年)。老年人(≥60 岁)和儿童<5 岁的疾病负担较高,流感是主要原因。在婴儿<1 岁时,RSV 是最大的负担。

结论

与 BCoDE 研究一致,本分析结果显示西班牙免疫预防呼吸道感染的负担仍然很高,并且首次强调了由 RSV 引起的大量 DALY。这些估计为指导预防策略和做出公共卫生决策提供了依据,以便在西班牙优先干预措施和分配医疗保健资源。

相似文献

1
Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain.使用残疾调整生命年(DALYs)评估西班牙十二种免疫预防传染病对人群健康的影响。
BMC Infect Dis. 2024 Aug 5;24(1):779. doi: 10.1186/s12879-024-09637-x.
2
Impact of infectious diseases on population health using incidence-based disability-adjusted life years (DALYs): results from the Burden of Communicable Diseases in Europe study, European Union and European Economic Area countries, 2009 to 2013.传染病对人口健康的影响,使用基于发病率的伤残调整生命年(DALYs):2009 至 2013 年欧洲传染病负担研究、欧盟和欧洲经济区国家的结果。
Euro Surveill. 2018 Apr;23(16). doi: 10.2807/1560-7917.ES.2018.23.16.17-00454.
3
Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the national immunisation programme in the Netherlands.荷兰全国免疫规划引入疫苗前,水痘与其他可通过疫苗预防的疾病的疾病负担比较。
Euro Surveill. 2019 May;24(18). doi: 10.2807/1560-7917.ES.2019.24.18.1800363.
4
Burden of Six Healthcare-Associated Infections on European Population Health: Estimating Incidence-Based Disability-Adjusted Life Years through a Population Prevalence-Based Modelling Study.六种医疗保健相关感染对欧洲人群健康的负担:通过基于人群患病率的建模研究估算基于发病率的伤残调整生命年
PLoS Med. 2016 Oct 18;13(10):e1002150. doi: 10.1371/journal.pmed.1002150. eCollection 2016 Oct.
5
Disease Burden of 32 Infectious Diseases in the Netherlands, 2007-2011.2007 - 2011年荷兰32种传染病的疾病负担
PLoS One. 2016 Apr 20;11(4):e0153106. doi: 10.1371/journal.pone.0153106. eCollection 2016.
6
Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.204 个国家和地区 1990-2019 年 369 种疾病和伤害导致的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet. 2020 Oct 17;396(10258):1204-1222. doi: 10.1016/S0140-6736(20)30925-9.
7
National disability-adjusted life years (DALYs) for 257 diseases and injuries in Ethiopia, 1990-2015: findings from the global burden of disease study 2015.1990 - 2015年埃塞俄比亚257种疾病和损伤的全国残疾调整生命年(DALYs):全球疾病负担研究2015的结果
Popul Health Metr. 2017 Jul 21;15(1):28. doi: 10.1186/s12963-017-0146-0.
8
A Software Tool for Estimation of Burden of Infectious Diseases in Europe Using Incidence-Based Disability Adjusted Life Years.一种使用基于发病率的伤残调整生命年估算欧洲传染病负担的软件工具。
PLoS One. 2017 Jan 20;12(1):e0170662. doi: 10.1371/journal.pone.0170662. eCollection 2017.
9
The national burden of cerebrovascular diseases in Spain: a population-based study using disability-adjusted life years.西班牙脑血管疾病的国家负担:一项基于人群的使用伤残调整生命年的研究。
Med Clin (Barc). 2015 Apr 20;144(8):353-9. doi: 10.1016/j.medcli.2013.11.040. Epub 2014 May 23.
10
Global burden associated with 85 pathogens in 2019: a systematic analysis for the Global Burden of Disease Study 2019.2019 年与 85 种病原体相关的全球负担:2019 年全球疾病负担研究的系统分析。
Lancet Infect Dis. 2024 Aug;24(8):868-895. doi: 10.1016/S1473-3099(24)00158-0. Epub 2024 Apr 16.

本文引用的文献

1
Economic evaluations of immunization programs as an indispensable tool for policymakers.免疫规划经济评价:决策者不可或缺的工具
BMC Health Serv Res. 2023 Nov 22;23(1):1284. doi: 10.1186/s12913-023-10071-z.
2
Respiratory syncytial virus-associated hospitalization in children aged <2 years in Spain from 2018 to 2021.西班牙 2018 年至 2021 年 2 岁以下儿童因呼吸道合胞病毒感染而住院的情况。
Hum Vaccin Immunother. 2023 Aug 1;19(2):2231818. doi: 10.1080/21645515.2023.2231818. Epub 2023 Jul 12.
3
Clinical and economic hospital burden of acute respiratory infection (BARI) due to respiratory syncytial virus in Spanish children, 2015-2018.
2015-2018 年西班牙儿童因呼吸道合胞病毒导致的急性呼吸道感染(BARI)的临床和经济医院负担。
BMC Infect Dis. 2023 Jun 8;23(1):385. doi: 10.1186/s12879-023-08358-x.
4
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe.呼吸道合胞病毒感染婴儿的经济负担及与健康相关的生活质量:欧洲一项多国前瞻性队列研究
Vaccine. 2023 Apr 17;41(16):2707-2715. doi: 10.1016/j.vaccine.2023.03.024. Epub 2023 Mar 21.
5
Excess hospitalizations and mortality associated with seasonal influenza in Spain, 2008-2018.2008-2018 年西班牙季节性流感相关的超额住院和死亡。
BMC Infect Dis. 2023 Feb 7;23(1):86. doi: 10.1186/s12879-023-08015-3.
6
Burden of Hospitalizations Related to Pneumococcal Infection in Spain (2016-2020).西班牙肺炎球菌感染相关住院负担(2016 - 2020年)
Antibiotics (Basel). 2023 Jan 14;12(1):172. doi: 10.3390/antibiotics12010172.
7
Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials.尼塞利珠单抗预防早产儿和足月儿呼吸道合胞病毒下呼吸道感染的疗效,以及对伴有先天性心脏病和慢性肺部疾病的婴儿的药代动力学外推:一项随机对照试验的汇总分析。
Lancet Child Adolesc Health. 2023 Mar;7(3):180-189. doi: 10.1016/S2352-4642(22)00321-2. Epub 2023 Jan 9.
8
What RSV interventions are in the research pipeline?呼吸道合胞病毒(RSV)有哪些干预措施正在研究中?
CMAJ. 2023 Jan 9;195(1):E19-E20. doi: 10.1503/cmaj.1096031.
9
Clinical and economic burden of physician-diagnosed influenza in adults during the 2017/2018 epidemic season in Spain.西班牙 2017/2018 流行季期间,医生诊断的成人流感的临床和经济负担。
BMC Public Health. 2022 Dec 17;22(1):2369. doi: 10.1186/s12889-022-14732-2.
10
Impact of Respiratory Syncytial Virus and Influenza Virus Infection in the Adult Population in Spain between 2012 and 2020.2012 年至 2020 年期间西班牙成人人群中呼吸道合胞病毒和流感病毒感染的影响。
Int J Environ Res Public Health. 2022 Nov 9;19(22):14680. doi: 10.3390/ijerph192214680.